TradingView
Rocketman
Mar 21, 2024 8:14 PM

NVO: Super-Duper-To-Go Long

Novo Nordisk A/SNYSE

Description

Fundamentals:
An insulin and diabetes drug care company based in Denmark. Booming fundamentals, booming funds, great cashflow, stable earnings and accelerating sales. Pays a little dividend.

Technicals:
Shallow pb
uHd
extreme indicator
34%-50% pb
a-b-c pb completion
horizonal support
kijun bounce
strong volume today at support

Outlook:
Expected to hold for 8 to 12 months. Expected to double in price within 8 months. Target 260 within 12 months.

Comment


NVO giving us a healthy retracement right at the beginning of Q2 an NFP Friday.
This might be the fourth week of negative retracement into longer-term support. If the price closes below 125, then there is potential for a weekly shallow pb trade. Besides this, I watch and wait and sit on my hands and let the market and history play out.

Comment


uHd and triangle breakout
More